Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kymera Therapeutics, Inc. (KYMR)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,339,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 414,105 1,300,163
Total Buy Value $0 $0 $5,301,325 $25,027,880
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 8
Total Shares Sold 846,935 906,367 906,367 2,944,621
Total Sell Value $35,475,904 $37,488,861 $37,488,861 $99,885,268
Total People Sold 5 6 6 7
Total Sell Transactions 16 19 19 49
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 204
  Page 4 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-10-17 4 OE $2.08 $124,243 D/D 59,732 561,931     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-08-22 4 B $26.00 $14,183,650 D/D 545,525 257,754 2.39     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-05-27 4 B $14.78 $966,337 D/D 65,369 230,637 2.39     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-05-26 4 B $14.21 $3,183,984 D/D 224,057 227,414 2.39     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-05-20 4 B $14.00 $141,394 D/D 10,100 216,772 2.39     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-05-06 4 B $19.26 $1,925,500 D/D 100,000 216,735 2.39     -
   Lampert Mark N See Remarks and Footnotes   –       •      –    2022-05-05 4 B $19.60 $2,939,865 D/D 150,000 212,604 2.39     -
   Gollob Jared Chief Medical Officer   •       –      –    2022-05-04 4 OE $1.31 $33,740 D/D 20,000 57,257     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-05-03 4 OE $2.08 $41,600 D/D 20,000 502,199     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2022-05-03 4 OE $2.08 $41,600 D/D 20,000 60,814     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 13,300 40,814     -
   Gollob Jared Chief Medical Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 12,600 37,257     -
   Caughey Elaine Chief Business Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 7,000 7,000     -
   Lampert Mark N See Explanation of Responses   –       –      –    2022-01-31 4 B $40.70 $1,400,406 D/D 34,408 1,395,925 2.44     -
   Lampert Mark N See Explanation of Responses   –       –      –    2022-01-27 4 B $38.33 $3,676,068 D/D 95,901 1,381,602 2.44     -
   Lampert Mark N See Explanation of Responses   –       –      –    2022-01-24 4 B $37.76 $10,300,637 D/D 272,767 1,343,743 2.44     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2022-01-14 4 OE $2.08 $20,800 D/D 10,000 27,514     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-14 4 OE $2.08 $20,800 D/D 10,000 482,199     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2022-01-12 4 AS $51.21 $777,684 D/D (15,000) 17,514     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2022-01-12 4 OE $2.08 $31,200 D/D 15,000 32,514     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-12 4 AS $51.31 $448,551 D/D (8,612) 472,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-12 4 OE $2.08 $17,913 D/D 8,612 480,811     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-11 4 AS $53.68 $913,795 D/D (16,923) 472,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-11 4 OE $2.08 $35,200 D/D 16,923 489,122     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-10 4 AS $52.46 $1,196,397 D/D (22,465) 472,199     -
  204 Records found
  1  2  3  4  5  6  7  8  9   
  Page 4 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us